XBiotech

About XBiotech

XBiotech Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of True Human monoclonal antibodies derived from natural human immunity. The company develops a pipeline of antibody therapies targeting a range of diseases, including cancer, vascular disease, inflammatory and infectious diseases, and diabetes. XBiotech's proprietary technology harnesses natural human antibodies to address unmet medical needs, with a focus on innovative treatments that minimize harmful side effects.